# Grard A. P. Nieuwenhuijzen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/grard-a-p-nieuwenhuijzen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 30,350 |
| Field | Esophageal Cancer Research and Treatment |
| h-index | 80 |
| i10-index | 276 |
| Last Known Institution | Radboud University Nijmegen |
| OpenAlex ID | https://openalex.org/A5037535575 |
| ORCID iD | https://orcid.org/0000-0002-5837-5513 |
| Works | 521 |

## Researcher papers

- [Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer](https://scholariq.org/papers/preoperative-chemoradiotherapy-for-esophageal-or-junctional-cancer/)
- [Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial](https://scholariq.org/papers/neoadjuvant-chemoradiotherapy-plus-surgery-versus-surgery-alone-for-oesophageal/)
- [Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial](https://scholariq.org/papers/short-course-radiotherapy-followed-by-chemotherapy-before-total-mesorectal/)
- [Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial](https://scholariq.org/papers/ten-year-outcome-of-neoadjuvant-chemoradiotherapy-plus-surgery-for-esophageal/)
- [Laparoscopic Versus Open Gastrectomy for Gastric Cancer (LOGICA): A Multicenter Randomized Clinical Trial](https://scholariq.org/papers/laparoscopic-versus-open-gastrectomy-for-gastric-cancer-logica-a-multicenter/)
- [Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer](https://scholariq.org/papers/factors-affecting-outcomes-following-pelvic-exenteration-for-locally-recurrent/)
- [Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study](https://scholariq.org/papers/safety-and-effectiveness-of-sgm-101-a-fluorescent-antibody-targeting/)

## Researcher topics

- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Colorectal Cancer Surgical Treatments](https://scholariq.org/topics/colorectal-cancer-surgical-treatments/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Esophageal and GI Pathology](https://scholariq.org/topics/esophageal-and-gi-pathology/)

## Researcher university

- [Radboud University Nijmegen](https://scholariq.org/institutions/radboud-university-nijmegen/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.